COVINA, CA--(MARKET WIRE)--Jun 5, 2007 -- Healtheuniverse Inc. (Other OTC:HLUN.PK - News), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that the Company’s adipose derived stem cell technology is under development for use in the $15 billion worldwide plastic surgery and cosmetic surgery market. The Company intends to sell its proprietary technology through packaged products and licensing agreements, once human clinical trials are completed, to plastic and cosmetic surgeons as a simple way for the industry to utilize our proprietary technology worldwide.
